Prostate Cancer Radiotherapy
Definitive VMAT, SBRT, and post-surgical salvage radiotherapy for localized, locally advanced, and recurrent prostate cancer.
Curative precision radiation matching surgical cure rates with superior urinary continence.
Large randomized trials (including the landmark ProtecT trial) have established that modern image-guided radiotherapy achieves cancer cure rates identical to radical prostatectomy for localized prostate cancer, with significantly lower risks of long-term urinary incontinence.
Treatment is customized using risk stratification based on PSA levels, Gleason grade group, and multiparametric MRI / 68Ga-PSMA PET/CT staging.
Options include ultra-precise 5-fraction Prostate SBRT, standard moderately hypofractionated IMRT/VMAT (4 to 5 weeks), and postoperative salvage radiation for rising PSA after surgery.
Key Clinical Considerations in Your Consultation
Every recommendation is customized according to staging scans, pathology markers, and patient priorities.
Definitive VMAT / IMRT with daily image guidance (IGRT) for localized disease
Ultra-hypofractionated 5-session Prostate SBRT for eligible candidates
Early salvage radiotherapy for post-prostatectomy biochemical recurrence
Pelvic lymph node irradiation and duration-tailored Androgen Deprivation Therapy (ADT)
Rectal spacer and hydrogel placement for zero rectal toxicity
Unbiased surgery vs. radiotherapy second-opinion consultations
Discuss Prostate Cancer Radiotherapy
Bring biopsy reports, recent PET/CT or MRI scans, and operative summaries for a comprehensive consultation.